FDA improves access to reports of adverse drug reactions

FDA

28 September 2017 - New online tool makes it easier for users to search the FDA Adverse Event Reporting System.

The U.S. FDA today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA’s Adverse Event Reporting System (FAERS). The tool is designed to make it easier for consumers, providers, and researchers to access this information.

"Tools like the FDA Adverse Event Reporting System are critical to the FDA’s ability to help ensure the greatest level of transparency and help patients and providers make safe use of drug and biologic products after they are approved by the FDA," said FDA Commissioner Scott Gottlieb, M.D. "The FDA is committed to fully informing patients and providers of adverse events reported with medical products and this enhanced portal now provides patients, doctors and others with easier access to the data they are interested in."

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Regulation , Process , Safety